Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
2
50%
Ph not_applicable
1
25%
Ph phase_3
1
25%

Phase Distribution

0

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution4 total trials
Phase 3Large-scale testing
1(25.0%)
Phase 4Post-market surveillance
2(50.0%)
N/ANon-phased studies
1(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(2)
Other(2)

Detailed Status

Completed2
unknown2

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 31 (25.0%)
Phase 42 (50.0%)
N/A1 (25.0%)

Trials by Status

completed250%
unknown250%

Recent Activity

0 active trials
Showing 4 of 4
completednot_applicable

Impact of Treatment With VENARUS® on the Level of Monocyte Chemoattractant Protein 1 in Varicose Veins Blood

NCT04933591
unknownphase_3

Evaluation of The Effect of Loratadine Versus Diosmin/Hesperidin Combination on Vinca Alkaloids Induced Neuropathy

NCT05243706
unknownphase_4

Endovascular Versus Medical Treatment for the Pelvic Congestion Syndrome

NCT04358497
completedphase_4

Clinical Non-inferiority Study Between Diosmin 600mg & Diosmin + Hesperidin in Symptomatic Chronic Venous Insufficiency

NCT03471910

Clinical Trials (4)

Showing 4 of 4 trials
NCT04933591Not Applicable

Impact of Treatment With VENARUS® on the Level of Monocyte Chemoattractant Protein 1 in Varicose Veins Blood

Completed
NCT05243706Phase 3

Evaluation of The Effect of Loratadine Versus Diosmin/Hesperidin Combination on Vinca Alkaloids Induced Neuropathy

Unknown
NCT04358497Phase 4

Endovascular Versus Medical Treatment for the Pelvic Congestion Syndrome

Unknown
NCT03471910Phase 4

Clinical Non-inferiority Study Between Diosmin 600mg & Diosmin + Hesperidin in Symptomatic Chronic Venous Insufficiency

Completed

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4